Propylene glycol toxicity associated with lorazepam infusion in a patient receiving continuous veno-venous hemofiltration with dialysis

Anesthesia and Analgesia

Volumn 94, Issue 6, 2002, Pages 1583-1585

  Al Khafaji, Ali H ^a   Dewhirst, William E ^a   Manning, Harold L ^a  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL; LORAZEPAM; MIDAZOLAM; PROPYLENE GLYCOL;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; FATALITY; HEMOFILTRATION; HUMAN; MALE; METABOLIC ACIDOSIS; PRIORITY JOURNAL;

EID: 0036265681     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/00000539-200206000-00039     Document Type: Article

References (9)

1. Osmolar gap metabolic acidosis in a 60-year old man treated for hypoxemic respiratory failure
2. Propylene glycol toxicity in a patient receiving intravenous diazepam
3. Propyleneglycole intoxication due to intravenous nitroglycerine
4. Hyperlactatemia, increased osmolar gap, and renal dysfunction during continuous lorazepam infusion
5. Propylene glycol toxicity related to high-dose lorazepam infusion: Case report and discussion
6. Propylene glycol toxicity following continuous etomidate infusion for the control of refractory cerebral edema
7. Propylene glycol pharmacokinetics and effects after intravenous infusion in humans
8. Kinetics of propylene glycol elimination and metabolism in rat